PMID- 28373782
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200930
IS  - 1016-7315 (Print)
IS  - 2212-5043 (Electronic)
IS  - 1016-7315 (Linking)
VI  - 29
IP  - 2
DP  - 2017 Apr
TI  - Congestive heart failure disease management program: 1-Year population experience 
      from a tertiary center heart failure registry in Saudi Arabia.
PG  - 90-95
LID - 10.1016/j.jsha.2016.07.002 [doi]
AB  - AIMS: We aimed to evaluate congestive heart failure (CHF) multidisciplinary 
      disease management program (DMProg) impact on mortality, readmission rates, 
      length of stay (LOS), and gender health characteristics. METHODS AND RESULTS: 
      This was a quasi-observational, pre- and post-trial with a parallel nonequivalent 
      group. We enrolled 174 inpatients having CHF with reduced ejection fraction and 
      New York Heart Association (NYHA) Class II-IV, and a total of 197 hospital 
      admissions. A comparative follow-up was performed from 15 December 2014 to 15 
      December 2015. Among 197 consecutive hospital admissions, 76 (39%) were included 
      in the preintervention or usual care group and 121 (61%) were assigned to the 
      postintervention group. After 1 year, in comparison with the preintervention 
      group, the postintervention group had shorter average LOS in days (7.6 days vs. 
      11.1 days, p < 0.002), lower 1-year readmission rate (36% vs. 57%, p < 0.003), 
      and lower in-house mortality (1.6% vs. 7.8%, p = 0.03), but similar baseline 
      mortality scores (38.2 vs. 38.6, p = 0.7), 30-day and 90-day readmission rates 
      (15% vs. 18.3%, p = 0.62 and 27.6% vs. 30%, p = 0.65), and 30-day readmission 
      risk score (24.9% vs. 26.2%, p = 0.09). By regression analysis, the DMProg 
      intervention was an independent factor for 1-year readmission reduction 
      (p = 0.001). Kaplan-Meier survival analysis favored the postintervention group 
      (log-rank, p < 0.001). CONCLUSION: DMProg significantly decreased 1-year 
      readmission rates, LOS, and in-house mortality.
FAU - Salem, Khal
AU  - Salem K
AD  - Cardiac Centre, King Abdullah Medical City (KAMC), Makkah, aSaudi Arabia.
FAU - Fallata, Dania
AU  - Fallata D
AD  - Cardiac Centre, King Abdullah Medical City (KAMC), Makkah, aSaudi Arabia.
FAU - ElSebaie, Maha
AU  - ElSebaie M
AD  - Cardiac Centre, King Abdullah Medical City (KAMC), Makkah, aSaudi Arabia; Zagazig 
      University, Cairo, bEgypt.
FAU - Montasser, Ahmad
AU  - Montasser A
AD  - Cardiac Centre, King Abdullah Medical City (KAMC), Makkah, aSaudi Arabia.
FAU - ElGedamy, Khaled
AU  - ElGedamy K
AD  - Cardiac Centre, King Abdullah Medical City (KAMC), Makkah, aSaudi Arabia.
FAU - ElKhateeb, Osama
AU  - ElKhateeb O
AD  - Cardiac Centre, King Abdullah Medical City (KAMC), Makkah, aSaudi Arabia.
LA  - eng
PT  - Journal Article
DEP - 20160721
PL  - Saudi Arabia
TA  - J Saudi Heart Assoc
JT  - Journal of the Saudi Heart Association
JID - 9887261
PMC - PMC5366667
OTO - NOTNLM
OT  - Disease management program
OT  - Heart failure
OT  - Middle East
OT  - Saudi Arabia
EDAT- 2017/04/05 06:00
MHDA- 2017/04/05 06:01
PMCR- 2016/07/21
CRDT- 2017/04/05 06:00
PHST- 2016/03/04 00:00 [received]
PHST- 2016/07/04 00:00 [revised]
PHST- 2016/07/15 00:00 [accepted]
PHST- 2017/04/05 06:00 [entrez]
PHST- 2017/04/05 06:00 [pubmed]
PHST- 2017/04/05 06:01 [medline]
PHST- 2016/07/21 00:00 [pmc-release]
AID - S1016-7315(16)30127-0 [pii]
AID - 10.1016/j.jsha.2016.07.002 [doi]
PST - ppublish
SO  - J Saudi Heart Assoc. 2017 Apr;29(2):90-95. doi: 10.1016/j.jsha.2016.07.002. Epub 
      2016 Jul 21.